"N Engl J Med"[journal] 检索结果

181. Reduction of Antihypertensive Treatment in Nursing Home Residents. Reply.

作者: Athanase Benetos.;Sylvie Gautier.;Patrick Rossignol.
来源: N Engl J Med. 2026年394卷9期932-933页

182. Reduction of Antihypertensive Treatment in Nursing Home Residents.

作者: Shigeo Fuji.
来源: N Engl J Med. 2026年394卷9期932页

183. Reduction of Antihypertensive Treatment in Nursing Home Residents.

作者: Lin Zhang.;Lidan Yang.
来源: N Engl J Med. 2026年394卷9期931-932页

184. Reduction of Antihypertensive Treatment in Nursing Home Residents.

作者: Justine Huart.;François Jouret.
来源: N Engl J Med. 2026年394卷9期931页

185. Reduction of Antihypertensive Treatment in Nursing Home Residents.

作者: Youyi Lu.;Lin Li.
来源: N Engl J Med. 2026年394卷9期930-931页

186. Reduction of Antihypertensive Treatment in Nursing Home Residents.

作者: Timo E Strandberg.
来源: N Engl J Med. 2026年394卷9期930页

187. Deferring Arterial Catheterization in Critically Ill Patients with Shock. Reply.

作者: Grégoire Muller.;Thierry Boulain.
来源: N Engl J Med. 2026年394卷9期929-930页

188. Deferring Arterial Catheterization in Critically Ill Patients with Shock.

作者: Javier Muñoz.
来源: N Engl J Med. 2026年394卷9期929页

189. Deferring Arterial Catheterization in Critically Ill Patients with Shock.

作者: Joseph Shiber.;Emily Fontane.
来源: N Engl J Med. 2026年394卷9期928-929页

190. Deferring Arterial Catheterization in Critically Ill Patients with Shock.

作者: Michael Thy.;Albin Mainar.
来源: N Engl J Med. 2026年394卷9期928页

191. Microbial Flora in War Wounds from the Ukrainian Front Line.

作者: Kostyantyn Dumchev.;Patrick Mc Gann.;Oleksandr Danyliuk.;Magda Metreveli.;Thomas A Musich.;Jason W Bennett.
来源: N Engl J Med. 2026年394卷9期926-928页

192. Restoring Function to a Variant of p53 in Solid Tumors.

作者: Xin Lu.
来源: N Engl J Med. 2026年394卷9期922-925页

193. Hitting the Mark - Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer.

作者: Hope S Rugo.
来源: N Engl J Med. 2026年394卷9期918-920页

194. Case 7-2026: A 91-Year-Old Man with Left Knee Pain.

作者: Sandra B Nelson.;Tina Shiang.;Erik T Newman.;Barbra M Blair.;Sarah M Schrader.
来源: N Engl J Med. 2026年394卷9期907-916页

195. Primary Measles Infection.

作者: Maximilian Lammer.;Barbara C Böckle.
来源: N Engl J Med. 2026年394卷9期906页

196. Group B Streptococcal Disease.

作者: Karen M Puopolo.
来源: N Engl J Med. 2026年394卷9期896-905页

Group B streptococcus commonly colonizes the human gastrointestinal and genitourinary tracts and is the single most common bacterial cause of invasive infection among newborns in the United States. Intrapartum antibiotic prophylaxis is currently used to reduce the risk of group B streptococcal disease among pregnant persons and newborns. No strategies are currently available to prevent disease in later infancy or among nonpregnant adults. Vaccines against group B streptococcal disease that consist of capsular polysaccharides linked to protein antigens are in development and may provide a means of prevention for all at-risk populations.

197. Tecovirimat for the Treatment of Mpox.

作者: Jason Zucker.;William A Fischer.;Lu Zheng.;Caitlyn McCarthy.;Pooja T Saha.;Arzhang Cyrus Javan.;Alex Greninger.;Matthew M Hamill.;Kieron Leslie.;Kristina M Brooks.;Jonathan Berardi.;Davey Smith.;Lara Hosey.;Grace Aldrovandi.;Kathie Ferbas.;Cheryl Day.;Rachel A Bender Ignacio.;Robert Bolan.;Marshall J Glesby.;Raphael J Landovitz.;Anne F Luetkemeyer.;Juan Sierra Madero.;Rajesh T Gandhi.;Sharon Nachman.;Joe Eron.;Judith S Currier.;Timothy Wilkin.; .
来源: N Engl J Med. 2026年394卷9期884-895页

Tecovirimat is approved for smallpox treatment under the Food and Drug Administration Animal Rule on the basis of efficacy in nonhuman primate models of mpox (previously known as monkeypox). However, the clinical efficacy of tecovirimat against human clade II mpox is unclear.

198. Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.

作者: Ecaterina E Dumbrava.;Geoffrey I Shapiro.;Aparna R Parikh.;Melissa L Johnson.;Anthony W Tolcher.;John A Thompson.;Anthony B El-Khoueiry.;Andrae L Vandross.;Shivaani Kummar.;Dale R Shepard.;Kim LeDuke.;Lisa Sheehan.;Leila Alland.;Arshad Haque.;Deepika Jalota.;Marc Fellous.;Alison M Schram.
来源: N Engl J Med. 2026年394卷9期872-883页

Rezatapopt is an investigational, first-in-class, oral, selective p53 reactivator that specifically binds to Y220C-mutated p53, which stabilizes p53 in its wild-type conformation and restores its functionality.

199. Of Trust, AI, and Green Beans: NOS Episode 3.10.

来源: N Engl J Med. 2026年394卷9期e9页

200. Subacute Sclerosing Panencephalitis after Measles Infection.

作者: Michael S Kung.;John Ross Crawford.
来源: N Engl J Med. 2026年394卷9期e14页

结果排序

文献格式

出版时间

出版类型

出版语言